Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2 Study of Intraocular Pressure (IOP) Lowering Efficacy of Transdermal Latanoprost Therapy

NCT01426464 is registered in ClinicalTrials.gov with Nanduri, Padma, M.D., FACS as lead sponsor.

NCT NCT01426464
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01426464 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2 Study of Intraocular Pressure (IOP) Lowering Efficacy of Transdermal Latanoprost Therapy
Lead sponsor
Nanduri, Padma, M.D., FACS
Phase
Phase 2
Overall status
Unknown status
Start date
September 30, 2011
Completion date
December 31, 2011
Enrollment
22 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glaucoma